Other confounding factors that determine the outcome measures highlighted in this study include the highly significant differences in the proportions of patients with data at 1 year that varied from 46.4 to 82.3%.
← all excerpts
Appropriateness of quality standards for meaningful intercentre comparisons of aflibercept service provision for neovascular age-related macular degeneration.
1
—
—